Third Zostavax death prompts new warnings

Authorities are emphasising the importance of screening and alerting vulnerable patients to the risk

A third patient has died in Australia after receiving the live attenuated varicella-zoster vaccine, the TGA has reported.

The patient, who was taking prednisolone and had recently been on checkpoint inhibitors for metastatic melanoma, died from disseminated vaccine strain varicella-zoster virus infection a few weeks after receiving a Zostavax shot.

An expert panel convened by the medicines regulator determined the man should never have been administered the vaccine because of his severe immunocompromise and the